United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $776,550,129.77
- Nov. 21, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 2, 2015 | EVP | 6,000 | $127.73 | Sell | $766,380.00 | |
Dec. 31, 2014 | CEO | 2,211 | $131.35 | Sell | $290,414.85 | |
Dec. 30, 2014 | CEO | 10,000 | $130.80 | Sell | $1,308,000.00 | |
Dec. 29, 2014 | CEO | 2,592 | $131.75 | Sell | $341,496.00 | |
Dec. 26, 2014 | CEO | 9,662 | $131.85 | Sell | $1,273,934.70 | |
Dec. 24, 2014 | CEO | 2,211 | $130.35 | Sell | $288,203.85 | |
Dec. 23, 2014 | COO | 10,000 | $127.82 | Sell | $1,278,200.00 | |
Dec. 22, 2014 | CEO | 2,592 | $133.45 | Sell | $345,902.40 | |
Dec. 19, 2014 | Director | 1,500 | $131.47 | Sell | $197,205.00 | |
Dec. 18, 2014 | EVP | 10,750 | $130.03 | Sell | $1,397,822.50 | |
Dec. 18, 2014 | CEO | 9,662 | $129.06 | Sell | $1,246,977.72 | |
Dec. 18, 2014 | CFO | 10,000 | $131.11 | Sell | $1,311,100.00 | |
Dec. 17, 2014 | CEO | 2,211 | $126.04 | Sell | $278,674.44 | |
Dec. 15, 2014 | CEO | 2,592 | $129.75 | Sell | $336,312.00 | |
Dec. 11, 2014 | CEO | 9,662 | $130.98 | Sell | $1,265,528.76 | |
Dec. 10, 2014 | CEO | 2,211 | $132.77 | Sell | $293,554.47 | |
Dec. 9, 2014 | COO | 10,000 | $134.80 | Sell | $1,348,000.00 | |
Dec. 8, 2014 | CEO | 2,592 | $132.34 | Sell | $343,025.28 | |
Dec. 4, 2014 | Director | 3,000 | $131.58 | Sell | $394,740.00 | |
Dec. 4, 2014 | EVP | 11,000 | $129.92 | Sell | $1,429,120.00 | |
Dec. 4, 2014 | CEO | 11,873 | $131.32 | Sell | $1,559,162.36 | |
Dec. 4, 2014 | CFO | 10,000 | $129.05 | Sell | $1,290,500.00 | |
Dec. 2, 2014 | COO | 10,000 | $133.63 | Sell | $1,336,300.00 | |
Dec. 1, 2014 | CEO | 2,592 | $132.92 | Sell | $344,528.64 | |
Nov. 28, 2014 | CEO | 11,873 | $132.77 | Sell | $1,576,378.21 | |
Nov. 25, 2014 | COO | 10,000 | $131.30 | Sell | $1,313,000.00 | |
Nov. 24, 2014 | CEO | 2,592 | $130.72 | Sell | $338,826.24 | |
Nov. 21, 2014 | COO | 10,000 | $130.15 | Sell | $1,301,500.00 | |
Nov. 20, 2014 | Director | 1,500 | $127.20 | Sell | $190,800.00 | |
Nov. 20, 2014 | EVP | 11,000 | $129.02 | Sell | $1,419,220.00 | |
Nov. 20, 2014 | CFO | 10,000 | $129.22 | Sell | $1,292,200.00 | |
Nov. 20, 2014 | CEO | 9,662 | $128.86 | Sell | $1,245,045.32 | |
Nov. 19, 2014 | CEO | 2,211 | $128.69 | Sell | $284,533.59 | |
Nov. 18, 2014 | COO | 10,000 | $128.21 | Sell | $1,282,100.00 | |
Nov. 17, 2014 | CEO | 2,592 | $125.65 | Sell | $325,684.80 | |
Nov. 13, 2014 | CEO | 9,662 | $124.79 | Sell | $1,205,720.98 | |
Nov. 12, 2014 | CEO | 2,211 | $122.88 | Sell | $271,687.68 | |
Nov. 10, 2014 | CEO | 2,592 | $125.14 | Sell | $324,362.88 | |
Nov. 7, 2014 | Director | 5,000 | $124.49 | Sell | $622,450.00 | |
Nov. 7, 2014 | COO | 10,000 | $124.46 | Sell | $1,244,600.00 | |
Nov. 6, 2014 | Director | 1,500 | $122.89 | Sell | $184,335.00 | |
Nov. 6, 2014 | CEO | 4,115 | $125.33 | Sell | $515,732.95 | |
Nov. 6, 2014 | EVP | 5,000 | $125.02 | Sell | $625,100.00 | |
Nov. 5, 2014 | CEO | 2,211 | $124.31 | Sell | $274,849.41 | |
Nov. 3, 2014 | CEO | 2,592 | $127.49 | Sell | $330,454.08 | |
Oct. 30, 2014 | CEO | 9,662 | $130.42 | Sell | $1,260,118.04 | |
Oct. 29, 2014 | CEO | 2,211 | $131.10 | Sell | $289,862.10 | |
Oct. 27, 2014 | CEO | 2,592 | $132.16 | Sell | $342,558.72 | |
Oct. 23, 2014 | EVP | 11,000 | $127.04 | Sell | $1,397,440.00 | |
Oct. 23, 2014 | CEO | 11,873 | $129.97 | Sell | $1,543,133.81 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Nov. 21, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.